KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,584,500 | -39.5% | 3,855,000 | 0.0% | 0.84% | -30.4% |
| Q2 2023 | $88,626,450 | -22.4% | 3,855,000 | 0.0% | 1.20% | -29.0% |
| Q1 2023 | $114,223,650 | +18.9% | 3,855,000 | +0.1% | 1.69% | +17.9% |
| Q4 2022 | $96,096,000 | +103.5% | 3,850,000 | +77.5% | 1.44% | +64.7% |
| Q3 2022 | $47,224,000 | +90.4% | 2,169,230 | +72.2% | 0.87% | +78.0% |
| Q2 2022 | $24,809,000 | -28.2% | 1,260,000 | +54.3% | 0.49% | -22.3% |
| Q1 2022 | $34,554,000 | -1.0% | 816,500 | +48.5% | 0.63% | +6.2% |
| Q4 2021 | $34,920,000 | +30.4% | 550,000 | +20.7% | 0.59% | +41.1% |
| Q3 2021 | $26,771,000 | +1577.4% | 455,750 | +822.6% | 0.42% | +1730.4% |
| Q3 2020 | $1,596,000 | – | 49,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |